A citation-based method for searching scientific literature

Ahmad Elkouzi, Vinata Vedam-Mai, Robert S Eisinger, Michael S Okun. Nat Rev Neurol 2019
Times Cited: 76







List of co-cited articles
514 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Parkinson's disease.
Lorraine V Kalia, Anthony E Lang. Lancet 2015
22

Parkinson disease.
Werner Poewe, Klaus Seppi, Caroline M Tanner, Glenda M Halliday, Patrik Brundin, Jens Volkmann, Anette-Eleonore Schrag, Anthony E Lang. Nat Rev Dis Primers 2017
10

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.
M H Polymeropoulos, C Lavedan, E Leroy, S E Ide, A Dehejia, A Dutra, B Pike, H Root, J Rubenstein, R Boyer,[...]. Science 1997
10

Alpha-synuclein in Lewy bodies.
M G Spillantini, M L Schmidt, V M Lee, J Q Trojanowski, R Jakes, M Goedert. Nature 1997
10

Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease.
Timothy R Sampson, Justine W Debelius, Taren Thron, Stefan Janssen, Gauri G Shastri, Zehra Esra Ilhan, Collin Challis, Catherine E Schretter, Sandra Rocha, Viviana Gradinaru,[...]. Cell 2016
9

Pharmacological treatment of Parkinson disease: a review.
Barbara S Connolly, Anthony E Lang. JAMA 2014
638
7

Selective neuronal vulnerability in Parkinson disease.
D James Surmeier, José A Obeso, Glenda M Halliday. Nat Rev Neurosci 2017
353
6

A double-blind, delayed-start trial of rasagiline in Parkinson's disease.
C Warren Olanow, Olivier Rascol, Robert Hauser, Paul D Feigin, Joseph Jankovic, Anthony Lang, William Langston, Eldad Melamed, Werner Poewe, Fabrizio Stocchi,[...]. N Engl J Med 2009
536
6

The c-Abl inhibitor, nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease.
Senthilkumar S Karuppagounder, Saurav Brahmachari, Yunjong Lee, Valina L Dawson, Ted M Dawson, Han Seok Ko. Sci Rep 2014
128
6


Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.
Mike A Nalls, Nathan Pankratz, Christina M Lill, Chuong B Do, Dena G Hernandez, Mohamad Saad, Anita L DeStefano, Eleanna Kara, Jose Bras, Manu Sharma,[...]. Nat Genet 2014
6

Epidemiology of Parkinson's disease.
Lonneke M L de Lau, Monique M B Breteler. Lancet Neurol 2006
6

Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice.
Kelvin C Luk, Victoria Kehm, Jenna Carroll, Bin Zhang, Patrick O'Brien, John Q Trojanowski, Virginia M-Y Lee. Science 2012
6

α-Synuclein in Parkinson's disease.
Leonidas Stefanis. Cold Spring Harb Perspect Med 2012
475
6

Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease.
Seung Pil Yun, Tae-In Kam, Nikhil Panicker, SangMin Kim, Yumin Oh, Jong-Sung Park, Seung-Hwan Kwon, Yong Joo Park, Senthilkumar S Karuppagounder, Hyejin Park,[...]. Nat Med 2018
310
6

Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson's disease.
Alan Whone, Matthias Luz, Mihaela Boca, Max Woolley, Lucy Mooney, Sonali Dharia, Jack Broadfoot, David Cronin, Christian Schroers, Neil U Barua,[...]. Brain 2019
113
5

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.
C Warren Olanow, Karl Kieburtz, Per Odin, Alberto J Espay, David G Standaert, Hubert H Fernandez, Arvydas Vanagunas, Ahmed A Othman, Katherine L Widnell, Weining Z Robieson,[...]. Lancet Neurol 2014
334
5

Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease.
Anthony E Lang, Steven Gill, Nik K Patel, Andres Lozano, John G Nutt, Richard Penn, David J Brooks, Gary Hotton, Elena Moro, Peter Heywood,[...]. Ann Neurol 2006
670
5

Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial.
C Warren Olanow, Raymond T Bartus, Tiffany L Baumann, Stewart Factor, Nicholas Boulis, Mark Stacy, Dennis A Turner, William Marks, Paul Larson, Phillip A Starr,[...]. Ann Neurol 2015
151
5

First-in-human assessment of PRX002, an anti-α-synuclein monoclonal antibody, in healthy volunteers.
Dale B Schenk, Martin Koller, Daniel K Ness, Sue G Griffith, Michael Grundman, Wagner Zago, Jay Soto, George Atiee, Susanne Ostrowitzki, Gene G Kinney. Mov Disord 2017
109
5

100 years of Lewy pathology.
Michel Goedert, Maria Grazia Spillantini, Kelly Del Tredici, Heiko Braak. Nat Rev Neurol 2013
588
5

Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease.
Vanessa Brochard, Béhazine Combadière, Annick Prigent, Yasmina Laouar, Aline Perrin, Virginie Beray-Berthat, Olivia Bonduelle, Daniel Alvarez-Fischer, Jacques Callebert, Jean-Marie Launay,[...]. J Clin Invest 2009
627
5

Staging of brain pathology related to sporadic Parkinson's disease.
Heiko Braak, Kelly Del Tredici, Udo Rüb, Rob A I de Vos, Ernst N H Jansen Steur, Eva Braak. Neurobiol Aging 2003
5

Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
Alberto J Espay, Joaquin A Vizcarra, Luca Marsili, Anthony E Lang, David K Simon, Aristide Merola, Keith A Josephs, Alfonso Fasano, Francesca Morgante, Rodolfo Savica,[...]. Neurology 2019
82
5


Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
Dilan Athauda, Kate Maclagan, Simon S Skene, Martha Bajwa-Joseph, Dawn Letchford, Kashfia Chowdhury, Steve Hibbert, Natalia Budnik, Luca Zampedri, John Dickson,[...]. Lancet 2017
279
5

MDS clinical diagnostic criteria for Parkinson's disease.
Ronald B Postuma, Daniela Berg, Matthew Stern, Werner Poewe, C Warren Olanow, Wolfgang Oertel, José Obeso, Kenneth Marek, Irene Litvan, Anthony E Lang,[...]. Mov Disord 2015
5

Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease.
Diego Grassi, Shannon Howard, Minghai Zhou, Natalia Diaz-Perez, Nicolai T Urban, Debbie Guerrero-Given, Naomi Kamasawa, Laura A Volpicelli-Daley, Philip LoGrasso, Corinne Ida Lasmézas. Proc Natl Acad Sci U S A 2018
98
5

Parkinson's disease: Mechanisms, translational models and management strategies.
Chand Raza, Rabia Anjum, Noor Ul Ain Shakeel. Life Sci 2019
86
5


Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease.
Emily M Rocha, Briana De Miranda, Laurie H Sanders. Neurobiol Dis 2018
197
5

Randomized Delayed-Start Trial of Levodopa in Parkinson's Disease.
Constant V M Verschuur, Sven R Suwijn, Judith A Boel, Bart Post, Bas R Bloem, Johannes J van Hilten, Teus van Laar, Gerrit Tissingh, Alexander G Munts, Guenther Deuschl,[...]. N Engl J Med 2019
85
5

α-Synuclein strains cause distinct synucleinopathies after local and systemic administration.
W Peelaerts, L Bousset, A Van der Perren, A Moskalyuk, R Pulizzi, M Giugliano, C Van den Haute, R Melki, V Baekelandt. Nature 2015
630
5

Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs.
Delphine Charvin, Rossella Medori, Robert A Hauser, Olivier Rascol. Nat Rev Drug Discov 2018
16
25

The emerging role of Nrf2 in mitochondrial function.
Albena T Dinkova-Kostova, Andrey Y Abramov. Free Radic Biol Med 2015
399
5

Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinical Trial.
Joseph Jankovic, Ira Goodman, Beth Safirstein, Tonya K Marmon, Dale B Schenk, Martin Koller, Wagner Zago, Daniel K Ness, Sue G Griffith, Michael Grundman,[...]. JAMA Neurol 2018
112
5

A phase I study of aromatic L-amino acid decarboxylase gene therapy for Parkinson's disease.
Shin-ichi Muramatsu, Ken-ichi Fujimoto, Seiya Kato, Hiroaki Mizukami, Sayaka Asari, Kunihiko Ikeguchi, Tadataka Kawakami, Masashi Urabe, Akihiro Kume, Toshihiko Sato,[...]. Mol Ther 2010
198
3

Functional recovery in parkinsonian monkeys treated with GDNF.
D M Gash, Z Zhang, A Ovadia, W A Cass, A Yi, L Simmerman, D Russell, D Martin, P A Lapchak, F Collins,[...]. Nature 1996
774
3

A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor.
W Jeffrey Elias, Nir Lipsman, William G Ondo, Pejman Ghanouni, Young G Kim, Wonhee Lee, Michael Schwartz, Kullervo Hynynen, Andres M Lozano, Binit B Shah,[...]. N Engl J Med 2016
403
3

Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial.
Peter A LeWitt, Robert A Hauser, Rajesh Pahwa, Stuart H Isaacson, Hubert H Fernandez, Mark Lew, Marie Saint-Hilaire, Emmanuelle Pourcher, Lydia Lopez-Manzanares, Cheryl Waters,[...]. Lancet Neurol 2019
36
8

Magnetic resonance imaging-guided phase 1 trial of putaminal AADC gene therapy for Parkinson's disease.
Chadwick W Christine, Krystof S Bankiewicz, Amber D Van Laar, R Mark Richardson, Bernard Ravina, Adrian P Kells, Brendon Boot, Alastair J Martin, John Nutt, Marin E Thompson,[...]. Ann Neurol 2019
46
6

Novel Focused Ultrasound Gene Therapy Approach Noninvasively Restores Dopaminergic Neuron Function in a Rat Parkinson's Disease Model.
Brian P Mead, Namho Kim, G Wilson Miller, David Hodges, Panagiotis Mastorakos, Alexander L Klibanov, James W Mandell, Jay Hirsh, Jung Soo Suk, Justin Hanes,[...]. Nano Lett 2017
58
5

Safety and tolerability of putaminal AADC gene therapy for Parkinson disease.
C W Christine, P A Starr, P S Larson, J L Eberling, W J Jagust, R A Hawkins, H F VanBrocklin, J F Wright, K S Bankiewicz, M J Aminoff. Neurology 2009
261
3

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease.
Steven S Gill, Nikunj K Patel, Gary R Hotton, Karen O'Sullivan, Renée McCarter, Martin Bunnage, David J Brooks, Clive N Svendsen, Peter Heywood. Nat Med 2003
915
3

Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial.
William J Marks, Jill L Ostrem, Leonard Verhagen, Philip A Starr, Paul S Larson, Roy Ae Bakay, Robin Taylor, Deborah A Cahn-Weiner, A Jon Stoessl, C Warren Olanow,[...]. Lancet Neurol 2008
391
3

Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease.
Kenneth A Follett, Frances M Weaver, Matthew Stern, Kwan Hur, Crystal L Harris, Ping Luo, William J Marks, Johannes Rothlind, Oren Sagher, Claudia Moy,[...]. N Engl J Med 2010
734
3


The global prevalence of dementia: a systematic review and metaanalysis.
Martin Prince, Renata Bryce, Emiliano Albanese, Anders Wimo, Wagner Ribeiro, Cleusa P Ferri. Alzheimers Dement 2013
3

Endoplasmic reticulum stress is important for the manifestations of α-synucleinopathy in vivo.
Emanuela Colla, Philippe Coune, Ying Liu, Olga Pletnikova, Juan C Troncoso, Takeshi Iwatsubo, Bernard L Schneider, Michael K Lee. J Neurosci 2012
233
3



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.